Managing Leadership Risk in PE Portfolio Companies Calibre One - 16 Jun 2026 Mitigating the True Cost of a Bad C-Suite Hire in 2026 Calibre One - 15 Jun 2026 The Strategic CFO for Private Equity Portfolio Companies: A 2026 Leadership Guide Calibre One - 29 May 2026 Succession Planning: A Strategic Guide for C-Suite Continuity in PE Calibre One - 20 May 2026 The Modern CFO: Defining Strategic Financial Leadership in 2026 Calibre One - 15 May 2026 PE Portfolio Company Executive Hiring: A Strategic Guide for Value Creation in 2026 Calibre One - 14 May 2026 How Healthcare, Advanced Technology, and FinTech Are Redefining Finance Leadership Calibre One - 12 Jan 2026 From Crisis to Clarity: How Executive Teams Are Evolving in the Post-COVID Era Calibre One - 03 Oct 2025 Beyond ESG Backlash: Why Investors Aren’t Shying Away from Energy Transition Calibre One - 08 Jul 2025 A Thoughtful Look at CEO-Chair Separation: What Boards Should Consider in 2025 Calibre One - 03 Jul 2025 Jed Donelly joins Calibre One as Partner Calibre One - 27 Jun 2025 Neurocrine Biosciences appoints Sanjay Keswani as CMO Calibre One - 11 Jun 2025 Show more